bamlanivimab

bamlanivimab · Eli Lilly Nederland B.V.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for bamlanivimab, covering 2021-03-11 to 2024-12-13. Get the full timeline:

Most recent: EMA Withdrawn from rolling review: Bamlanivimab and etesevimab for COVID-19 (bamlanivimab;Etesevimab) — Eli Lilly Nederland B.V.